Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: May 5, 2023
Date Accepted: Dec 7, 2023

The final, peer-reviewed published version of this preprint can be found here:

Application of eHealth Tools in Anticoagulation Management After Cardiac Valve Replacement: Scoping Review Coupled With Bibliometric Analysis

Wu Y, Wang X, Zhou M, Huang Z, Liu l, Cong L

Application of eHealth Tools in Anticoagulation Management After Cardiac Valve Replacement: Scoping Review Coupled With Bibliometric Analysis

JMIR Mhealth Uhealth 2024;12:e48716

DOI: 10.2196/48716

PMID: 38180783

PMCID: 10799280

Application of eHealth tools in anticoagulation management after cardiac valve replacement: scoping review coupled with bibliometric analysis

  • Ying Wu; 
  • Xiaohui Wang; 
  • Mengyao Zhou; 
  • Zhuoer Huang; 
  • lijuan Liu; 
  • Li Cong

ABSTRACT

Background:

Background:

Anticoagulant therapy plays a vital role in thrombotic and hemorrhagic complications among patients who were undergoing cardiac valve replacement (CVR). The emergence of electronic health (eHealth) tools provides new prospects for long-term anticoagulant management after CVR. However, there is no comprehensive summary of the application of eHealth tools in anticoagulation management after CVR.

Objective:

Objective:

To investigate the application status and effect of eHealth tools in the anticoagulation management of patients after CVR, and to provide future direction for the development of eHealth tools in anticoagulation management.

Methods:

Methods:

This scoping review follows the 5-step framework developed by Arksey and O'Malley, and employs scientometric analysis to determine available evidence. PubMed, MEDLINE, WOS, CINAHL, and Embase databases were searched from the database inception to 1 March 2023. VOSviewer 1.6.18 was used to display the overlay visualization and clustering analysis of keywords, as well as the cooperation networks between countries, institutions, and authors.

Results:

Results:

Twenty-four researches meeting the criteria were analyzed. eHealth tools mainly include computer-based support systems, electronic health records, telemedicine platforms, and mobile applications. Compared to traditional anticoagulation management, eHealth tools can effectively improve the anticoagulation effect of patients after valve replacement (such as achieving a target international normalized ratio, time in therapeutic range, and reducing bleeding or thrombotic complications). Italy has the largest number of publications and the widest cooperative relationship. Remote management, machine learning, and artificial intelligence have been popular research directions in anticoagulation management after CVR.

Conclusions:

Conclusions:

E-Health tools have potential clinical applications in anticoagulation management after CVR, which can improve postoperative rehabilitation and reduce the incidence of adverse events. However, further research is needed to explore its long-term effectiveness and the potential risks and challenges associated with its use and development.


 Citation

Please cite as:

Wu Y, Wang X, Zhou M, Huang Z, Liu l, Cong L

Application of eHealth Tools in Anticoagulation Management After Cardiac Valve Replacement: Scoping Review Coupled With Bibliometric Analysis

JMIR Mhealth Uhealth 2024;12:e48716

DOI: 10.2196/48716

PMID: 38180783

PMCID: 10799280

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.